Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

635 ARTÍCULOS , VIENDO DEL 436 AL 450

Postoperative Cognitive Dysfunction and the Protective Effects of Enriched Environment: A Systematic Review

Hua M, Min J.

Neurodegener Dis. 2020;20(4):113-122. doi: 10.1159/000513196. Epub 2021 Feb 18.

Immunological and hormonal mechanisms in Alzheimer's disease

Trifu SC, Ţîbîrnă A, Drăgoi AM, Cristea BM.

Rom J Morphol Embryol. 2020 Oct-Dec;61(4):1033-1038. doi: 10.47162/RJME.61.4.05.

Circadian disturbances in Alzheimer's disease progression: a prospective observational cohort study of community-based older adults

Li P, Gao L, Gaba A, Yu L, Cui L, Fan W, Lim ASP, Bennett DA, Buchman AS, Hu K.

Lancet Healthy Longev. 2020 Dec;1(3):e96-e105. doi: 10.1016/s2666-7568(20)30015-5. Epub 2020 Nov 12.

Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease

Shi Y, Gu L, Wang Q, Gao L, Zhu J, Lu X, Zhou F, Zhu D, Zhang H, Xie C, Zhang Z.

J Gerontol A Biol Sci Med Sci. 2020 Mar 9;75(4):664-670. doi: 10.1093/gerona/glz005.

The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia

Hazen J, Vistnes M, Barca ML, Eldholm RS, Persson K, Brækhus A, Saltvedt I, Selbæk G, Engedal K, Knapskog AB.

Alzheimer Dis Assoc Disord. 2020 Jan-Mar;34(1):47-53. doi: 10.1097/WAD.0000000000000342.

Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease

Cantero JL, Atienza M, Lage C, Zaborszky L, Vilaplana E, Lopez-Garcia S, Pozueta A, Rodriguez-Rodriguez E, Blesa R, Alcolea D, Lleo A, Sanchez-Juan P, Fortea J; Alzheimer’s Disease Neuroimaging Initiative.

Cereb Cortex. 2020 Apr 14;30(4):2083-2098. doi: 10.1093/cercor/bhz224.

Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward

Alber J, Goldfarb D, Thompson LI, Arthur E, Hernandez K, Cheng D, DeBuc DC, Cordeiro F, Provetti-Cunha L, den Haan J, Van Stavern GP, Salloway SP, Sinoff S, Snyder PJ.

Alzheimers Dement. 2020 Jan;16(1):229-243. doi: 10.1002/alz.12006.

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort

Westwood S, Baird AL, Anand SN, Nevado-Holgado AJ, Kormilitzin A, Shi L, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Baker S, Buckley NJ, Ten Kate M, Scheltens P, Teunissen CE, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lléo A, Sala I, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Legido-Quigley C, Bertram L, Barkhof F, Zetterberg H, Morgan BP, Streffer J, Visser PJ, Lovestone S.

J Alzheimers Dis. 2020;74(1):213-225. doi: 10.3233/JAD-190434.

Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical Setting

Jung NY, Kim ES, Kim HS, Jeon S, Lee MJ, Pak K, Lee JH, Lee YM, Lee K, Shin JH, Ko JK, Lee JM, Yoon JA, Hwang C, Choi KU, Lee EC, Seong JK, Huh GY, Kim DS, Kim EJ.

J Alzheimers Dis. 2020;74(2):473-490. doi: 10.3233/JAD-191109.

Down syndrome and dementia: advances in the field

McGlinchey E, McCallion P, McCarron M.

Curr Opin Psychiatry. 2020 May;33(3):278-283. doi: 10.1097/YCO.0000000000000589.

18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease

Okafor M, Nye JA, Shokouhi M, Shaw LM, Goldstein F, Hajjar I.

J Alzheimers Dis. 2020;74(2):589-601. doi: 10.3233/JAD-191330.

Interactions between Personality, Depression, Anxiety and Cognition to Understand Early Stage of Alzheimer's Disease

Zufferey V, Gunten AV, Kherif F.

Curr Top Med Chem. 2020;20(9):782-791. doi: 10.2174/1568026620666200211110545.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias